Your browser doesn't support javascript.
loading
Update on optimal management for pancreatic cancer: expert perspectives from members of the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty.
Nguyen, Mike; Segelov, Eva; Goldstein, David; Pavlakis, Nick; Shapiro, Jeremy; Price, Timothy J; Nagrial, Adnan; Chantrill, Lorraine; Leong, Trevor; Chen, John; Burge, Matt; Karapetis, Christos S; Chau, Ian; Lordick, Florian; Renouf, Daniel; Tebbutt, Niall; Roy, Amitesh C.
Afiliación
  • Nguyen M; Department of Medical Oncology, School of Clinical Sciences, Monash University and Monash Health, Melbourne, Australia.
  • Segelov E; Department of Medical Oncology, School of Clinical Sciences, Monash University and Monash Health, Melbourne, Australia.
  • Goldstein D; Department of Medical Oncology, Prince of Wales Hospital, University of NSW, Sydney, Australia.
  • Pavlakis N; Department of Medical Oncology, Royal North Shore Hospital, University of Sydney, Sydney, Australia.
  • Shapiro J; Cabrini Health, Monash University, Melbourne, Australia.
  • Price TJ; Department of Haematology and Oncology, The Queen Elizabeth Hospital/University of Adelaide, Adelaide, Australia.
  • Nagrial A; Department of Medical Oncology, Westmead & Blacktown Hospitals, University of Sydney, Sydney, Australia.
  • Chantrill L; Department Medical Oncology, Wollongong Hospital, Illawarra Shoalhaven Local Health District, Australia.
  • Leong T; Division of Radiation Oncology, Peter MacCallum Cancer Centre, The University of Melbourne, Melbourne, Australia.
  • Chen J; Flinders Centre for Innovation in Cancer, Flinders University, Bedford Park, Australia.
  • Burge M; Department of Cancer Care Services, Royal Brisbane Hospital, University of Queensland, Herston, Australia.
  • Karapetis CS; Flinders Centre for Innovation in Cancer, Flinders University, Bedford Park, Australia.
  • Chau I; Department of Medicine, Royal Marsden Hospital, Institute of Cancer Research, Surrey, London, UK.
  • Lordick F; University Cancer Center Leipzig and Department of Oncology, Gastroenterology, Hepatology, Pneumology and Infectious Diseases, Leipzig University Medical Center, Leipzig, Germany.
  • Renouf D; Department of Medical Oncology, BC Cancer. Faculty of Medicine, University of British Columbia, Vancouver, Canada.
  • Tebbutt N; Department of Medical Oncology, Olivia Newton-John Cancer Wellness and Research Centre. Austin Health, Heidelberg, Australia.
  • Roy AC; Flinders Centre for Innovation in Cancer, Flinders University, Bedford Park, Australia.
Expert Rev Anticancer Ther ; 22(1): 39-51, 2022 Jan.
Article en En | MEDLINE | ID: mdl-34739362
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Expert Rev Anticancer Ther Asunto de la revista: NEOPLASIAS / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Expert Rev Anticancer Ther Asunto de la revista: NEOPLASIAS / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Australia